ALIMENTARY PHARMACOLOGY & THERAPEUTICS, vol.38, no.9, pp.1038-1044, 2013 (SCI-Expanded)
BackgroundCoffee consumption may modulate the risk of the metabolic syndrome (MetS) and non-alcoholic fatty liver disease (NAFLD).